Enterprise Clinical AI for Hospitals:
Measurable Outcomes,
Controlled Deployment.

Qmed AI is Qmed Asia’s enterprise artificial intelligence portfolio for healthcare systems.

It spans clinical documentation, guideline intelligence, patient navigation, disease screening, workforce optimisation, revenue cycle automation, and agent-based workflow orchestration. Modules can operate independently or together as a hospital-wide AI platform.

Qmed AI is designed for:

• Hospital groups and health systems
• Public healthcare networks
• Teaching hospitals
• Screening programmes
• Research and quality teams

No.

Qmed AI supports clinicians, nurses, and operations teams by automating documentation, coordination, and analysis.

Clinical judgement and final responsibility always remain with licensed professionals.

Patient safety and responsible AI are embedded through:

• Clinical governance committees
• Audit trails and versioned workflows
• Escalation thresholds for high-risk scenarios
• Human-in-the-loop review
• Transparency in patient-facing modules
• Separation of clinical logic from commercial priorities

Hospitals typically assess Qmed AI through pilots using measurable indicators such as:

• Clinician time saved
• Reduced overtime and agency staffing
• Faster admissions or discharge processing
• Improved screening throughput
• Reduced reporting backlogs
• Improved documentation completeness

Yes.

Qmed AI is modular.

Hospitals often start with one department or workflow and expand across multiple sites and functions over time.

Qmed AI focuses on:

• Real hospital workflows
• Enterprise governance readiness
• Public-sector collaboration experience
• Malaysian clinical context
• Research-driven development
• Multi-site hospital deployments

Commercial models vary by module and scope and may include subscription licensing, enterprise agreements, and usage-based pricing structures.